13F

CRSP CRISPR Therapeutics AG

2026Q1 · CUSIP H17182108 · Sector: Healthcare & Biotech

Cooling · Breadth rolling over
Holders
489
Δ holders QoQ
+7
Breadth percentile
Top 37%
Whale holders
155
Δ whales
+1
Inst. holding value
$3.6B
New positions
81
Closed positions
74
Price momentum (1Q)
Put / Call
12/22

Breadth history (34 quarters)

2018Q1: Δ+50 · h=132 2018Q2: Δ+36 · h=168 2018Q3: Δ+12 · h=180 2018Q4: Δ-24 · h=156 2019Q1: Δ+11 · h=167 2019Q2: Δ+11 · h=178 2019Q3: Δ+4 · h=182 2019Q4: Δ+65 · h=247 2020Q1: Δ+3 · h=250 2020Q2: Δ+17 · h=267 2020Q3: Δ+33 · h=300 2020Q4: Δ+106 · h=406 2021Q1: Δ+31 · h=437 2021Q2: Δ+55 · h=492 2021Q3: Δ-20 · h=472 2021Q4: Δ-30 · h=442 2022Q1: Δ-3 · h=439 2022Q2: Δ-8 · h=431 2022Q3: Δ+0 · h=431 2022Q4: Δ-32 · h=399 2023Q1: Δ-21 · h=378 2023Q2: Δ+33 · h=411 2023Q3: Δ-8 · h=403 2023Q4: Δ+68 · h=471 2024Q1: Δ+13 · h=484 2024Q2: Δ-35 · h=449 2024Q3: Δ-34 · h=415 2024Q4: Δ-9 · h=406 2025Q1: Δ-11 · h=395 2025Q2: Δ+40 · h=435 2025Q3: Δ+4 · h=439 2025Q4: Δ+43 · h=482 2026Q1: Δ+7 · h=489 2018Q1: holders=132 2018Q2: holders=168 2018Q3: holders=180 2018Q4: holders=156 2019Q1: holders=167 2019Q2: holders=178 2019Q3: holders=182 2019Q4: holders=247 2020Q1: holders=250 2020Q2: holders=267 2020Q3: holders=300 2020Q4: holders=406 2021Q1: holders=437 2021Q2: holders=492 2021Q3: holders=472 2021Q4: holders=442 2022Q1: holders=439 2022Q2: holders=431 2022Q3: holders=431 2022Q4: holders=399 2023Q1: holders=378 2023Q2: holders=411 2023Q3: holders=403 2023Q4: holders=471 2024Q1: holders=484 2024Q2: holders=449 2024Q3: holders=415 2024Q4: holders=406 2025Q1: holders=395 2025Q2: holders=435 2025Q3: holders=439 2025Q4: holders=482 2026Q1: holders=489 -106 -53 +0 +53 +106 118318517 18Q119Q120Q121Q122Q123Q124Q125Q126Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 14 lit events

Period Percentile Next-1Q return Next-2Q return
2025Q4 Top 12%
2025Q2 Top 6%
2023Q4 Top 6%
2023Q2 Top 5%
2021Q2 Top 2%
2021Q1 Top 10%
2020Q4 Top 4%
2020Q3 Top 6%

Options Sentiment

Put holders
12
QoQ: -2
Call holders
22
QoQ: -1

See methodology →

Fundamentals

PE (TTM)
EPS (TTM)
$-6.17
EPS YoY
Revenue (TTM)
$0.0B
Revenue YoY
-89.1%
Quarterly Revenue & EPS (4Y)
2022-06-30: $0M 2022-09-30: $0M 2022-12-31: $0M 2023-03-31: $100M 2023-06-30: $70M 2023-09-30: $0M 2023-12-31: $201M 2024-03-31: $1M 2024-06-30: $1M 2024-09-30: $1M 2024-12-31: $36M 2025-03-31: $1M 2025-06-30: $1M 2025-09-30: $1M 2025-12-31: $1M 2026-03-31: $1M 2022-06-30: EPS -2.40 2022-09-30: EPS -2.24 2022-12-31: EPS -1.40 2023-03-31: EPS -0.67 2023-06-30: EPS -0.98 2023-09-30: EPS -1.41 2023-12-31: EPS 1.12 2024-03-31: EPS -1.43 2024-06-30: EPS -1.49 2024-09-30: EPS -1.01 2024-12-31: EPS -0.41 2025-03-31: EPS -1.58 2025-06-30: EPS -2.40 2025-09-30: EPS -1.17 2025-12-31: EPS -1.32 2026-03-31: EPS -1.28 0M 101M 201M $M -2.64 -0.70 1.23 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

As of 2026-03-31 · SEC filings (XBRL)